Skip to content
Close
Contact
Calendar
Materials Library
Announcements
Announcements
Weekly View
Journal Articles
About
About ICER
Funding
Staff
Affiliated Researchers
Advisory and Governance Boards
Independent Voting Committees
Comparative Effectiveness Research Awards
Membership
Policies
Careers
Assessments
Ulcerative Colitis
Nonalcoholic Steatohepatitis
Hemophilia A
Acute Migraine
Sickle Cell Disease
Cystic Fibrosis
Beta Thalassemia
Completed Assessments
Methods
How We Do our Work
Value Assessment Framework
Stakeholder Engagement
Commentaries
Donate
Menu
Close
About
About ICER
Funding
Staff
Affiliated Researchers
Advisory and Governance Boards
Independent Voting Committees
Comparative Effectiveness Research Awards
Membership
Policies
Careers
Assessments
Methods
Methodology
How We Do our Work
Patient, Manufacturer, and Other Stakeholder Engagement
Policies that Guide our Work
Commentaries
Materials
Global Calendar
Announcements
Donate
Contact
Commentaries
Morningstar’s Report on Socially Conscious Investment Strategies
02/14/2020
How Independent Assessment of Drug Value Can Help States
02/07/2020
Fixing Our Broken Drug Pricing System: Patient Engagement Is the Necessary First Step
01/29/2020
The Tradeoffs Podcast: The Price of Innovation
01/24/2020
Overheard at J.P. Morgan: Perspectives on EQRx
01/17/2020
ICER’s Commitment to Patient Engagement
01/10/2020
Happy 2020, Everyone!
01/03/2020
Rounding Up the Top Stories From 2019 & Wishing You a Healthy 2020
12/20/2019
Unique Perspectives on Drug Pricing
12/17/2019
ICER’s Annual Policy Summit: Fair Access
12/06/2019
To ensure that our reports are as useful as possible to our stakeholders, we would like to get a better sense of how they are being used. You will be redirected to the report after answering these brief questions.
Which category best describes your perspective?
*
Select One
Academic/Researcher
Clinical Society
Employer/Purchaser
Health Care Provider
Hospital/Provider Organization/ACO
Life Sciences Manufacturer
Media
Patient/Consumer
Policymaker/Government Official
Private Payer/PBM
Public Payer
Other
Other
How do you intend to use this material
*
Please check all that apply.
To inform treatment decisions or guidelines
To inform state policy
To inform federal policy
To inform public comment/feedback to ICER
To inform coverage decisions and contracting policies
To inform pricing
Other
If Other, please describe
